Use of Genetic Test Information in Life Insurance: An Evaluation of Different Regulatory Models
-
Margaret Otlowski
Introduction
The new knowledge from the Human Genome Project has created much interest and anticipation of improved health for the population. A significant aspect of this has been the expanded use of genetic testing to identify whether a person has the affected gene and is therefore at risk of developing a particular condition or, in the case of conditions inherited on an autosomal dominant basis, establishing that a person is presymptomatic of a condition that they will almost certainly develop. Whilst knowledge of genetic risk can be of great benefit, in allowing life-planning in the knowledge of that risk, and in some cases, taking of preventative measures, concerns have been generated about the availability of genetic test information, and the use that commercial third parties may seek to make of this information.
© Walter de Gruyter
Articles in the same Issue
- Editorial
- The Coexistence of Genetically Modified Crops with Other Forms of Farming: The Regulation by EU Member States in the Light of EC Law
- Use of Genetic Test Information in Life Insurance: An Evaluation of Different Regulatory Models
- The International Treatment of Biological Material as Intellectual Property
- Application of the ‘Precautionary Principle’ in the 2000 Biosafety Protocol to the 1992 Convention on Biological Diversity
- The new EU Regulatory Framework for GM Food (Part I) Procedural aspects: safety assessment, authorisation and administrative review
- Regulation on Agricultural Genetically Modified Organisms in Australia
- Biotechnology Law in The Socialist Republic of Vietnam
Articles in the same Issue
- Editorial
- The Coexistence of Genetically Modified Crops with Other Forms of Farming: The Regulation by EU Member States in the Light of EC Law
- Use of Genetic Test Information in Life Insurance: An Evaluation of Different Regulatory Models
- The International Treatment of Biological Material as Intellectual Property
- Application of the ‘Precautionary Principle’ in the 2000 Biosafety Protocol to the 1992 Convention on Biological Diversity
- The new EU Regulatory Framework for GM Food (Part I) Procedural aspects: safety assessment, authorisation and administrative review
- Regulation on Agricultural Genetically Modified Organisms in Australia
- Biotechnology Law in The Socialist Republic of Vietnam
